Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Pozycja w akcjach #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Cena akcji
$0.16328419
Kapitalizacja rynkowa
$204.14K
Zmiana (1 dzień)
4.35%
Zmiana (1 rok)
102.45%
Kraj
GB
Handel Fusion Antibodies plc (FAB)

Kategoria

Historia ceny akcji dla Fusion Antibodies plc (FAB)
Najwyższa cena zamknięcia: $0.17 dnia 2026-03-01

Najniższa cena zamknięcia: $2.40 dnia 2017-12-01
Historia cen akcji firmy Fusion Antibodies plc od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -21.78%
2025 153.61%
2024 38.42%
2023 -88.93%
2022 -66.99%
2021 -1.91%
2020 55.79%
2019 51.91%
2018 -71.85%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$36.82 -51.12%
DK
$451.24 -11.82%
US
$736.53 11.43%
US
$294.88 52.33%
BE
$681.85 12.16%
NL